| Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003 P Patel, DL Hanson, PS Sullivan, RM Novak, AC Moorman, TC Tong, ... Annals of internal medicine 148 (10), 728-736, 2008 | 1090 | 2008 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 919 | 2022 |
| Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine SM Hammer, ME Sobieszczyk, H Janes, ST Karuna, MJ Mulligan, ... New England Journal of Medicine 369 (22), 2083-2092, 2013 | 709 | 2013 |
| COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets TM Delorey, CGK Ziegler, G Heimberg, R Normand, Y Yang, ... Nature 595 (7865), 107-113, 2021 | 604 | 2021 |
| Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment–naive patients significantly impact treatment outcomes BB Simen, JF Simons, KH Hullsiek, RM Novak, RD MacArthur, JD Baxter, ... The Journal of infectious diseases 199 (5), 693-701, 2009 | 467 | 2009 |
| AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study K Buchacz, RK Baker, FJ Palella Jr, JS Chmiel, KA Lichtenstein, ... Aids 24 (10), 1549-1559, 2010 | 412 | 2010 |
| Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death DR Boulware, KH Hullsiek, CE Puronen, A Rupert, JV Baker, MA French, ... Journal of Infectious Diseases 203 (11), 1637-1646, 2011 | 363 | 2011 |
| Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults FH Priddy, D Brown, J Kublin, K Monahan, DP Wright, J Lalezari, ... Clinical infectious diseases 46 (11), 1769-1781, 2008 | 322 | 2008 |
| Cumulative incidence of cancer among persons with HIV in North America: a cohort study MJ Silverberg, B Lau, CJ Achenbach, Y Jing, KN Althoff, G D'Souza, ... Annals of internal medicine 163 (7), 507-518, 2015 | 315 | 2015 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 264 | 2023 |
| Effect of bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities: a randomized clinical trial MS Cohen, A Nirula, MJ Mulligan, RM Novak, M Marovich, C Yen, ... Jama 326 (1), 46-55, 2021 | 204 | 2021 |
| Maraviroc: the first of a new class of antiretroviral agents RD MacArthur, RM Novak Clinical Infectious Diseases 47 (2), 236-241, 2008 | 197 | 2008 |
| Prevalence of antiretroviral drug resistance mutations in chronically HIV–infected, treatment-naive patients: implications for routine resistance screening before initiation of … RM Novak, L Chen, RD MacArthur, JD Baxter, KH Hullsiek, G Peng, ... Clinical infectious diseases 40 (3), 468-474, 2005 | 189 | 2005 |
| Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general … P Patel, DL Hanson, PS Sullivan, RM Novak, AC Moorman, TC Tong, ... Ann Intern Med 148 (10), 728-736, 2008 | 171 | 2008 |
| A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the … RD MacArthur, RM Novak, G Peng, L Chen, Y Xiang, KH Hullsiek, ... The Lancet 368 (9553), 2125-2135, 2006 | 169 | 2006 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 141 | 2021 |
| Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV … RM Novak, BA Donoval, PJ Graham, LA Boksa, G Spear, RC Hershow, ... Clinical and Vaccine Immunology 14 (9), 1102-1107, 2007 | 135 | 2007 |
| Microbiome composition and function drives wound-healing impairment in the female genital tract AS Zevin, IY Xie, K Birse, K Arnold, L Romas, G Westmacott, RM Novak, ... PLoS pathogens 12 (9), e1005889, 2016 | 131 | 2016 |
| Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ... The Lancet Respiratory Medicine 7 (11), 951-963, 2019 | 126 | 2019 |
| Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women GE Martin, M Gouillou, AC Hearps, TA Angelovich, AC Cheng, F Lynch, ... PloS one 8 (1), e55279, 2013 | 126 | 2013 |
